1 / 12

National IPR Policy: Takeaways for Pharma & Tech Industry

Explore the key highlights and benefits of India's National IPR Policy for the pharmaceutical and technology industries. Learn about expedited IP registration, stronger enforcement of IPR, commercialization opportunities, and support for researchers and innovators.

harrisonroberts
Download Presentation

National IPR Policy: Takeaways for Pharma & Tech Industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. National IPR Policy : Takeaways for Pharma & Tech Industry Nakul J. SharedalalIntellectual Property Attorney& Advocates Y.J. Trivedi & Co. Complete IP Solutions : India & Worldwide

  2. Rising levels of education are set to increase the acceptability of pharmaceuticals. • India’s patient pool is expected to increase to over 20% in the next 10 years, mainly due to the rise in population • Source : http://www.makeinindia.com/sector/pharmaceuticals/

  3. WHY THE NATIONAL IPR POLICY? STRENGTHEN THE IP INFRSTRUCTURE ATTRACT INVESTMENT MAKE ENVIRONMENT BUSINESS FRIENDLY FASTER IP PROCESS REVIEWING RULES & PROCUDURE AUTONOMY TO IPOs

  4. CREATION LEGAL FRAMEWORK MANAGEMENT OF IPOs AWARNESS NATIONAL IPR POLICY : THE OBJECTIVES HUMAN CAPITAL DEVELOPMENT COMMERCIALIZATION ENFORCEMENT

  5. "The country’s pharmaceuticals industry revenues are expected to expand at a CAGR of 12.1% during 2012-20 and reach USD 45 Billion. The healthcare sector in India is expected to grow to USD 250 Billion by 2020 from USD 65 Billion currently.” http://www.makeinindia.com/sector/pharmaceuticals

  6. What’s instored for Pharma Industry? Expedited IP Registration Process Stronger Enforcement of IPR IP Bank through Commercialization

  7. EXPEDITED IP REGISTRATION PROCESS • Financial Autonomy to IPOs • Online and Offline Availability of Document • Bridging all IPOs • Appointment of Public Relations Officer • Help Desk in all IPOs • Significantly adding staff to reduce backlog

  8. Stronger Enforcement of IPR Special IPR Courts Regionalizing IPAB as per IPOs Expert Patent Bench in High Courts (Metros)

  9. Commercialization • The IP Exchange Program • Incentives for companies with R & D units • First time fee benefits for MSMEs • Strategic registration and commercial plans for SMEs • Bank Loans for the less fortunate

  10. WHAT’S IN THE POLICY FOR RESEARCHERS, INNOVATORS? • In depth IP knowledge to be imparted to the innovators, researchers and the scientists through IP Awareness Program • IP Facilitation Centers with Nodal points for the complete access to national and global IP database • Will be counseled with need based individual strategies to score with their IPRs • Human Capital Development aims at IP education through training, nurturing, skill development of people from all sectors of society • Establishment of IP Institutions to cater nationwide awareness of IPR

  11. MISSES IN THE POLICY Trade Secrets IPR Budget

  12. Y.J. Trivedi & Co. Patents & Trademarks Attorneys First & Second Floor, City Square Building, Polytechnic Ahmedabad 380 015 Email : nakulj@yjtrivedi.com Handphone : +91-9924410700

More Related